查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621823

電子處方市場：按產品、交付模式和最終用戶分類 - 全球預測，2025-2030 年

ePrescribing Market by Offrings (Services, Solution), Delivery Mode (On premise, Web & Cloud based), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，電子處方市場價值為1.4753億美元，預計到2024年將達到1.5921億美元，複合年成長率為8.05%，預計到2030年將達到2.5379億美元。

電子處方或電子配藥是指醫療處方箋的數位化創建、傳輸和填寫，簡化了醫療服務提供者和藥房之間的流程。該技術對於減少處方箋錯誤、提高病人安全和提高醫療保健效率至關重要。電子處方系統通常應用於醫院、診所和藥局。在最終用戶中，醫院因其處方箋量大而佔據了很大的市場佔有率，但小型診所和零售藥局的採用率也有所增加。市場的關鍵成長要素包括對醫療保健 IT 解決方案的需求不斷增加、對減少用藥錯誤的日益關注以及政府為加速採用電子處方而做出的努力。向遠端醫療的日益轉變和不斷擴大的互通性標準帶來了顯著的機遇，為新參與企業和現有企業提供了針對不同醫療保健環境創新和客製化解決方案的途徑。為了利用這些機會，公司可以探索諸如整合人工智慧進行個人化藥物管理、增強安全功能以及改進用戶介面以提高易用性等方法。然而，這個市場面臨一些挑戰，例如與現有電子健康記錄(EHR) 系統的整合、初始投資較高以及對資料隱私和安全的擔憂。另一個限制是一些醫療專業人員抵制學習新技術。此外，不同地區的法規不同可能會使市場擴大策略變得複雜。研究和開發應專注於為小型診所開發具有成本效益的解決方案，提高資料共用能力，並確保遵守不斷變化的監管標準。對用於安全交易的區塊鏈和用於預測分析的機器學習的研究可以進一步推動市場發展。總體而言，市場是充滿活力的，其特點是逐漸走向全面數位健康整合，為能夠有效管理當前限制並利用我們提供的新興技術的公司提供了巨大的成長潛力。

主要市場統計
基準年[2023] 14753萬美元
預測年份 [2024] 1.5921億美元
預測年份 [2030] 2.5379億美元
複合年成長率（%） 8.05%

市場動態：揭示快速發展的電子處方市場的關鍵市場洞察

供需的動態交互作用正在改變電子處方市場。了解這些不斷變化的市場動態可以幫助公司做出明智的投資決策、改善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 促進電子配製系統使用的政府措施和法規
    • 更多採用電子健康記錄(EHR)
    • 對提高護理品質和病人安全的需求不斷成長
  • 市場限制因素
    • 初始設定和維護成本很高
  • 市場機會
    • 加大投資拓展新興地區業務，推動決策支援系統
    • 與遠端醫療的整合以及個人化醫療分析的利用
  • 市場問題
    • 對資料隱私和安全的擔憂

波特五力：駕馭電子處方市場的策略工具

波特五力：「框架是了解市場格局競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解電子處方市場的外部影響

外部宏觀環境因素在塑造電子處方市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解電子處方市場的競爭格局

對電子處方市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：電子處方市場供應商的績效評估

FPNV 定位矩陣是評估電子處方市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製電子處方市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對電子處方市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 促進電子配製系統使用的政府措施和法規
      • 更多採用電子健康記錄 (EHR)
      • 提高護理品質和病人安全的新要求
    • 抑制因素
      • 初始設定和維護成本很高
    • 機會
      • 擴大新興地區投資，改善決策支援系統
      • 與遠端醫療整合並利用分析實現個人化醫療
    • 任務
      • 資料隱私和安全問題
  • 市場區隔分析
    • 組件：整合解決方案適用於更廣泛的醫療保健 IT 系統
    • 部署：即時資料共用和更新推動雲端的採用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第 6 章 電子處方市場提供來源：透過提供

  • 介紹
  • 服務
    • 執行
    • 網路
  • 解決方案
    • 一體化
    • 獨立的

第7章電子處方市場：依交付模式

  • 介紹
  • 本地
  • 雲端基礎

第 8 章 電子處方市場：依最終使用者分類

  • 介紹
  • 醫院
  • 藥局
  • 醫生辦公室

第9章美洲電子處方市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區電子處方市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的電子處方市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Rhyl 為患者推出新的電子處方箋系統
    • DrFirst Healthcare Innovations 與 MEDITECH 合作推進加拿大的電子複合
    • BoomerangFX 與 DrFirst 合作，為北美美容醫療診所推出電子配藥
  • 戰略分析和建議

公司名單

  • 75health
  • Allscripts Healthcare Solutions Inc.
  • athenahealth, Inc.
  • Dosespot by PRN Software, LLC
  • DrChrono
  • DrFirst Inc.
  • eazyScripts Technology, LLC
  • eClinicalWorks
  • eMDs, Inc. by CompuGroup Medical
  • Epocrates Inc.
  • Healthie Inc.
  • iCoreConnect
  • Intelligent Medical Software
  • Kareo, Inc. by Tebra Technologies, Inc.
  • MDToolbox
  • MedicalMine Inc.
  • Networking Technology, Inc.
  • NextGen Healthcare, Inc.
  • Optum, Inc.
  • Oracle Corporation
  • Pabau
  • Provet Cloud
  • Qualifacts Systems, LLC
  • Surescripts, LLC
  • Wolters Kluwer NV
Product Code: MRR-351BAD5037B5

The ePrescribing Market was valued at USD 147.53 million in 2023, expected to reach USD 159.21 million in 2024, and is projected to grow at a CAGR of 8.05%, to USD 253.79 million by 2030.

ePrescribing, or electronic prescribing, refers to the digital creation, transmission, and filling of medical prescriptions, streamlining the process between healthcare providers and pharmacies. This technology is essential for reducing prescription errors, enhancing patient safety, and improving healthcare efficiency. ePrescribing systems are typically applied in hospitals, clinics, and pharmacies. Among end users, hospitals hold significant market share due to high prescription volume, but adoption is expanding across smaller practices and retail pharmacies. Key growth factors in the market include rising demand for healthcare IT solutions, increased focus on reducing medication errors, and government initiatives promoting the adoption of ePrescribing. The ongoing shift towards telemedicine and expanding interoperability standards present notable opportunities, providing avenues for new entrants and established players to innovate and tailor solutions for varied healthcare settings. To capitalize on these opportunities, companies can explore integrating AI for personalized medication management, enhancing cybersecurity features, and improving user interfaces for better usability. However, the market faces challenges such as integration with existing electronic health record (EHR) systems, high initial investments, and concerns regarding data privacy and security. Limitations also include resistance from some healthcare professionals due to the learning curve associated with new technology. Furthermore, regulatory variations across different regions can complicate market expansion strategies. Innovation and research should focus on developing cost-effective solutions aimed at smaller practices, improving data-sharing capabilities, and ensuring compliance with evolving regulatory standards. Research into blockchain for secure transactions and machine learning for predictive analytics could further drive market evolution. Overall, the market is dynamic, characterized by a progressive trend towards full digital health integration, offering substantial growth potential for those who can effectively manage current limitations and leverage emerging technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 147.53 million
Estimated Year [2024] USD 159.21 million
Forecast Year [2030] USD 253.79 million
CAGR (%) 8.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ePrescribing Market

The ePrescribing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and regulations promoting the use of e-prescribing systems
    • Increasing adoption of electronic health records (EHRs)
    • Emerging demand for improved healthcare quality and patient safety
  • Market Restraints
    • High initial setup and maintenance costs
  • Market Opportunities
    • Rising investments to expand in emerging regions, and advancements in decision support systems
    • Integration with telemedicine, leveraging analytics for personalized medicine
  • Market Challenges
    • Concerns about data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the ePrescribing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ePrescribing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ePrescribing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ePrescribing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ePrescribing Market

A detailed market share analysis in the ePrescribing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ePrescribing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ePrescribing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ePrescribing Market

A strategic analysis of the ePrescribing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include 75health, Allscripts Healthcare Solutions Inc., athenahealth, Inc., Dosespot by PRN Software, LLC, DrChrono, DrFirst Inc., eazyScripts Technology, LLC, eClinicalWorks, eMDs, Inc. by CompuGroup Medical, Epocrates Inc., Healthie Inc., iCoreConnect, Intelligent Medical Software, Kareo, Inc. by Tebra Technologies, Inc., MDToolbox, MedicalMine Inc., Networking Technology, Inc., NextGen Healthcare, Inc., Optum, Inc., Oracle Corporation, Pabau, Provet Cloud, Qualifacts Systems, LLC, Surescripts, LLC, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the ePrescribing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offrings, market is studied across Services and Solution. The Services is further studied across Implementation and Network. The Solution is further studied across Integrated, and Standalone.
  • Based on Delivery Mode, market is studied across On premise and Web & Cloud based.
  • Based on End User, market is studied across Hospitals, Pharmacies, and Physician Offices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and regulations promoting the use of e-prescribing systems
      • 5.1.1.2. Increasing adoption of electronic health records (EHRs)
      • 5.1.1.3. Emerging demand for improved healthcare quality and patient safety
    • 5.1.2. Restraints
      • 5.1.2.1. High initial setup and maintenance costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments to expand in emerging regions, and advancements in decision support systems
      • 5.1.3.2. Integration with telemedicine, leveraging analytics for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns about data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Suitability of integrated solutions for broader healthcare IT system
    • 5.2.2. Deployment: Inclination towards on-cloud deployment owing to real time data sharing and updates
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ePrescribing Market, by Offrings

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Implementation
    • 6.2.2. Network
  • 6.3. Solution
    • 6.3.1. Integrated,
    • 6.3.2. Standalone

7. ePrescribing Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. On premise
  • 7.3. Web & Cloud based

8. ePrescribing Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Pharmacies
  • 8.4. Physician Offices

9. Americas ePrescribing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ePrescribing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ePrescribing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Rhyl to Launch New Electronic Prescription System for Patients
    • 12.3.2. DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada
    • 12.3.3. BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 75health
  • 2. Allscripts Healthcare Solutions Inc.
  • 3. athenahealth, Inc.
  • 4. Dosespot by PRN Software, LLC
  • 5. DrChrono
  • 6. DrFirst Inc.
  • 7. eazyScripts Technology, LLC
  • 8. eClinicalWorks
  • 9. eMDs, Inc. by CompuGroup Medical
  • 10. Epocrates Inc.
  • 11. Healthie Inc.
  • 12. iCoreConnect
  • 13. Intelligent Medical Software
  • 14. Kareo, Inc. by Tebra Technologies, Inc.
  • 15. MDToolbox
  • 16. MedicalMine Inc.
  • 17. Networking Technology, Inc.
  • 18. NextGen Healthcare, Inc.
  • 19. Optum, Inc.
  • 20. Oracle Corporation
  • 21. Pabau
  • 22. Provet Cloud
  • 23. Qualifacts Systems, LLC
  • 24. Surescripts, LLC
  • 25. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. EPRESCRIBING MARKET RESEARCH PROCESS
  • FIGURE 2. EPRESCRIBING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRESCRIBING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPRESCRIBING MARKET DYNAMICS
  • TABLE 7. GLOBAL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRESCRIBING MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPRESCRIBING MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRESCRIBING MARKET SIZE, BY INTEGRATED,, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPRESCRIBING MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRESCRIBING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPRESCRIBING MARKET SIZE, BY WEB & CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPRESCRIBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRESCRIBING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPRESCRIBING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY OFFRINGS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023